Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 82.80%-172.31K | 98.34%-14.25K | 18.23%-2.02M | 92.48%-19.19K | 64.12%-142.03K | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K |
| Net income from continuing operations | 65.16%-504.59K | 89.90%-207.05K | -24.96%-3.62M | -10.61%-767.06K | 400.73%642.77K | -40.94%-1.45M | -112.66%-2.05M | 69.08%-2.9M | -19.62%-693.49K | 95.43%-213.74K |
| Operating gains losses | -143.57%-55.1K | -1,500.37%-341.37K | 165.01%198.4K | 132.53%186.04K | -376.23%-138.48K | 276.65%126.47K | -91.54%24.38K | -177.25%-305.18K | -987.26%-571.89K | -87.33%50.13K |
| Depreciation and amortization | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | 57.68%38.69K | -96.05%64.14K | 309.77%2.05M | 181.38%172.96K | 103.72%228.83K | -89.43%24.54K | 1,622.44%1.62M | -47.40%500.26K | -61.56%61.47K | -22.14%112.33K |
| Other non cashItems | -133.62%-48.67K | -1.10%45.97K | -1,446.47%-1.4M | -290.49%-888.12K | -29.92%-704.2K | 84.40%144.78K | 149.82%46.48K | -102.95%-90.6K | 165.88%466.22K | -115.40%-542.04K |
| Change In working capital | 163.25%397.36K | 184.12%424.06K | 134.09%752.87K | 164.63%1.28M | -186.58%-170.94K | -53.13%150.94K | 25.91%-504.13K | -90.63%321.61K | -53.37%482.55K | 1,156.44%197.44K |
| -Change in receivables | 85.41%-386 | -83.63%2.82K | 224.88%27.91K | 83.85%-4.31K | 2,059.71%17.66K | -111.06%-2.65K | 192.24%17.21K | -107.21%-22.35K | -272.68%-26.71K | 92.74%-901 |
| -Change in prepaid assets | -87.57%6.08K | 101.08%1.08K | 121.49%42.69K | -74.26%40.22K | 168.54%53.05K | -56.43%48.94K | 74.47%-99.52K | -133.37%-198.6K | 2.96%156.25K | -2,018.67%-77.4K |
| -Change in payables and accrued expense | 274.27%391.66K | 199.61%420.17K | 25.75%682.27K | 251.58%1.24M | -187.64%-241.65K | -43.67%104.65K | -55.11%-421.82K | -78.54%542.56K | -59.31%353.01K | 2,772.15%275.74K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 82.80%-172.31K | 98.34%-14.25K | 18.23%-2.02M | 92.48%-19.19K | 64.12%-142.03K | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -75.18%175K | -97.99%25K | -20.35%1.99M | -95.65%8.7K | -91.95%34.4K | 151.79%705K | -21.94%1.24M | 87.26%2.5M | 92.12%200K | -35.09%427.4K |
| Net issuance payments of debt | --25K | --0 | 308.07%1.22M | --0 | --0 | --0 | --1.22M | --300K | --300K | --0 |
| Net common stock issuance | ---- | ---- | -67.98%705K | --0 | --0 | 220.45%705K | --0 | 164.19%2.2M | -79.67%100K | -15.85%287.4K |
| Proceeds from stock option exercised by employees | --0 | --25K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | --63.34K | --8.7K | -75.43%34.4K | --0 | --20.24K | ---- | ---- | -55.82%140K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -75.18%175K | -97.99%25K | -20.35%1.99M | -95.65%8.7K | -91.95%34.4K | 151.79%705K | -21.94%1.24M | 87.26%2.5M | 92.12%200K | -35.09%427.4K |
| Net cash flow | ||||||||||
| Beginning cash position | -95.51%19K | -78.12%8.18K | 350.03%37.38K | -79.84%18.67K | 107.08%126.31K | 70.87%422.85K | 350.03%37.38K | -95.21%8.31K | 122.34%92.62K | 323.20%60.99K |
| Current changes in cash | 100.91%2.69K | -97.21%10.76K | -200.27%-29.21K | 80.97%-10.49K | -441.37%-107.63K | -59.04%-296.56K | 61.15%385.47K | 117.38%29.13K | -50.40%-55.13K | 31.40%31.53K |
| Effect of exchange rate changes | 3,561.54%476 | 2,000.00%63 | 114.29%8 | 96.12%-4 | -104.08%-4 | 192.86%13 | 108.11%3 | -102.32%-56 | -103.11%-103 | -96.99%98 |
| End cash Position | -82.45%22.16K | -95.51%19K | -78.12%8.18K | -78.12%8.18K | -79.84%18.67K | 107.08%126.31K | 70.87%422.85K | 350.03%37.38K | 350.03%37.38K | 122.34%92.62K |
| Free cash from | 82.80%-172.31K | 98.34%-14.25K | 18.23%-2.02M | 92.48%-19.19K | 64.12%-142.03K | -114.71%-1M | 36.60%-858.97K | -64.44%-2.47M | -81.26%-255.13K | 37.60%-395.87K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.